S Watanabe1, S Mizuno, L H Oshima
1Epidemiology Division, National Cancer Center, Tokyo 104, Japan.
Growth hormone (GH) therapy has been linked to leukemia development in 31 reported cases globally. Leukemia risk may be associated with early-life GH administration, with cases appearing during or after treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: